kabutan

PeptiDream Inc.(4587) Summary

4587
TSE Prime
PeptiDream Inc.
1,382.5
JPY
-34.5
(-2.43%)
Mar 13, 3:30 pm JST
8.67
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
1,373.2
Mar 13, 11:20 pm JST
Summary Chart Historical News Financial Result
PER
59.5
PBR
3.47
Yield
ー%
Margin Trading Ratio
8.94
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,387.0 JPY 8.71 USD
Previous Close Mar 12
1,417.0 JPY 8.91 USD
High Mar 13, 9:19 am
1,412.0 JPY 8.87 USD
Low Mar 13, 9:07 am
1,378.5 JPY 8.65 USD
Volume
897,600
Trading Value
1.25B JPY 7.81M USD
VWAP
1387.76 JPY 8.71 USD
Minimum Trading Value
138,250 JPY 867 USD
Market Cap
0.18T JPY 1.13B USD
Number of Trades
2,078
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
2,602
1-Year High Dec 3, 2025
9,661
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 145,700 2,111,900 14.49
Feb 27, 2026 127,300 2,335,500 18.35
Feb 20, 2026 158,100 2,416,000 15.28
Feb 13, 2026 103,800 1,673,700 16.12
Feb 6, 2026 102,100 1,723,400 16.88
Company Profile
PeptiDream Inc. is a drug discovery venture company that collaborates with major pharmaceutical companies to develop peptide-based drugs. The company has also acquired a radiopharmaceutical business.
Sector
Pharmaceuticals
PeptiDream Inc. is a biotech venture originating from the University of Tokyo, focusing primarily on drug discovery and development using special peptides through its proprietary drug discovery platform system, PDPS. The company engages in collaborative drug research and development using PDPS, technology licensing, and strategic partnerships to expand its in-house pipeline. Through its subsidiary PDR Pharma, PeptiDream Inc. also operates in the radiopharmaceutical business, conducting research, development, manufacturing, and sales of diagnostic and therapeutic radiopharmaceuticals. The company concentrates on developing diagnostic agents for imaging cancer and abnormal brain accumulations, as well as therapeutic radiopharmaceuticals targeting unmet medical needs, particularly in the field of oncology. As a group, PeptiDream Inc. operates across a wide range of areas including research, development, manufacturing, and sales of pharmaceuticals and related products.